PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
23.54
-0.26 (-1.09%)
At close: Nov 16, 2026, 4:00 PM EST
23.53
-0.01 (-0.04%)
Pre-market: Nov 17, 2026, 7:00 AM EST

PROCEPT BioRobotics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
352.31308.05224.5136.1975.0134.47
Revenue Growth
17.47%37.22%64.84%81.55%117.60%346.72%
Cost of Revenue
127.72111.8387.465.1437.9318.61
Gross Profit
224.59196.23137.171.0537.0915.87
Selling, General & Admin
265.57228.81171.42131.7788.8351.04
Research & Development
80.6371.2862.348.4528.9818.99
Operating Expenses
346.2300.09233.71180.22117.8170.03
Operating Income
-121.61-103.86-96.61-109.17-80.72-54.16
Interest Expense
-3.41-3.59-4.18-4-5.18-5.81
Interest & Investment Income
7.1812.2210.97.552.50.08
Other Non Operating Income (Expenses)
-0.16-0.16-1.14-0.2-0.490.05
EBT Excluding Unusual Items
-118-95.38-91.05-105.82-83.9-59.85
Other Unusual Items
3.2----3.26-
Pretax Income
-114.8-95.38-91.05-105.82-87.15-59.85
Income Tax Expense
0.060.190.370.08--
Net Income
-114.86-95.57-91.41-105.9-87.15-59.85
Net Income to Common
-114.86-95.57-91.41-105.9-87.15-59.85
Net Income Growth
------
Shares Outstanding (Basic)
575652474416
Shares Outstanding (Diluted)
575652474416
Shares Change
3.20%6.56%10.31%6.43%169.42%349.90%
EPS (Basic)
-2.02-1.72-1.75-2.24-1.96-3.63
EPS (Diluted)
-2.02-1.72-1.75-2.24-1.96-3.63
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-85.07-58.34-103.62-133.21-83.04-57.93
Free Cash Flow Per Share
-1.50-1.05-1.99-2.82-1.87-3.52
Gross Margin
63.75%63.70%61.07%52.17%49.44%46.02%
Operating Margin
-34.52%-33.72%-43.04%-80.16%-107.61%-157.12%
Profit Margin
-32.60%-31.02%-40.72%-77.76%-116.18%-173.62%
Free Cash Flow Margin
-24.15%-18.94%-46.16%-97.81%-110.69%-168.03%
EBITDA
-113.64-97.47-91.38-105.36-77.88-50.84
EBITDA Margin
-32.26%-31.64%-40.70%-77.36%-103.82%-147.48%
D&A For EBITDA
7.976.395.233.812.843.32
EBIT
-121.61-103.86-96.61-109.17-80.72-54.16
EBIT Margin
-34.52%-33.71%-43.04%-80.16%-107.61%-157.12%
Advertising Expenses
-0.60.50.30.10.1
SEC Filings: 10-K · 10-Q